Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Healthy male subjects~2. overweight or obese~Exclusion criteria:~1. Any relevant deviation from healthy conditions

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- BI 187004 CL (Type: EXPERIMENTAL): 1 single dose per subject as oral solution
- Placebo to BI 187004 CL (Type: PLACEBO_COMPARATOR): 1 single dose per subject as oral solution

Based on this trial design, predict the completion outcome and termination type (if applicable).